BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kong R, Luo H, Wang N, Li J, Xu S, Chen K, Feng J, Wu L, Li S, Liu T, Lu X, Xia Y, Shi Y, Zhou Y, He W, Dai Q, Zheng Y, Lu J. Portulaca Extract Attenuates Development of Dextran Sulfate Sodium Induced Colitis in Mice through Activation of PPARγ. PPAR Res 2018;2018:6079101. [PMID: 29483924 DOI: 10.1155/2018/6079101] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Liu C, Jiang Y, Liu G, Guo Z, Jin Q, Long D, Zhou W, Qian K, Zhao H, Liu K. PPARGC1A affects inflammatory responses in photodynamic therapy (PDT)-treated inflammatory bowel disease (IBD). Biochemical Pharmacology 2022. [DOI: 10.1016/j.bcp.2022.115119] [Reference Citation Analysis]
2 Luo H, Cao G, Luo C, Tan D, Vong CT, Xu Y, Wang S, Lu H, Wang Y, Jing W. Emerging Pharmacotherapy for Inflammatory Bowel Diseases. Pharmacological Research 2022. [DOI: 10.1016/j.phrs.2022.106146] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
3 Liu C, Zeng Y, Wen Y, Huang X, Liu Y. Natural Products Modulate Cell Apoptosis: A Promising Way for the Treatment of Ulcerative Colitis. Front Pharmacol 2022;13:806148. [DOI: 10.3389/fphar.2022.806148] [Reference Citation Analysis]
4 Kumar A, Sreedharan S, Kashyap AK, Singh P, Ramchiary N. A review on bioactive phytochemicals and ethnopharmacological potential of purslane (Portulaca oleracea L.). Heliyon 2022;8:e08669. [PMID: 35028454 DOI: 10.1016/j.heliyon.2021.e08669] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Shi B, Liu S, Huang A, Zhou M, Sun B, Cao H, Shan J, Sun B, Lin J. Revealing the Mechanism of Friedelin in the Treatment of Ulcerative Colitis Based on Network Pharmacology and Experimental Verification. Evid Based Complement Alternat Med 2021;2021:4451779. [PMID: 34765000 DOI: 10.1155/2021/4451779] [Reference Citation Analysis]
6 Mahoro P, Moon HJ, Yang HJ, Kim KA, Cha YS. Protective Effect of Gochujang on Inflammation in a DSS-Induced Colitis Rat Model. Foods 2021;10:1072. [PMID: 34066160 DOI: 10.3390/foods10051072] [Reference Citation Analysis]
7 Madboli AEA, Seif MM. Immunohistochemical, histopathological, and biochemical studies of the NF-ҡB P65 marker in rat ovaries experimentally intoxicated by cadmium and the protective effect of the purslane plant extract. Environ Sci Pollut Res Int 2021;28:17613-26. [PMID: 33400125 DOI: 10.1007/s11356-020-12209-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Decara J, Rivera P, López-Gambero AJ, Serrano A, Pavón FJ, Baixeras E, Rodríguez de Fonseca F, Suárez J. Peroxisome Proliferator-Activated Receptors: Experimental Targeting for the Treatment of Inflammatory Bowel Diseases. Front Pharmacol 2020;11:730. [PMID: 32536865 DOI: 10.3389/fphar.2020.00730] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
9 Lu PD, Zhao YH. Targeting NF-κB pathway for treating ulcerative colitis: comprehensive regulatory characteristics of Chinese medicines. Chin Med 2020;15:15. [PMID: 32063999 DOI: 10.1186/s13020-020-0296-z] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 9.5] [Reference Citation Analysis]
10 Wu L, Guo C, Wu J. Therapeutic potential of PPARγ natural agonists in liver diseases. J Cell Mol Med 2020;24:2736-48. [PMID: 32031298 DOI: 10.1111/jcmm.15028] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 8.5] [Reference Citation Analysis]
11 Venkataraman B, Ojha S, Belur PD, Bhongade B, Raj V, Collin PD, Adrian TE, Subramanya SB. Phytochemical drug candidates for the modulation of peroxisome proliferator-activated receptor γ in inflammatory bowel diseases. Phytother Res 2020;34:1530-49. [PMID: 32009281 DOI: 10.1002/ptr.6625] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
12 Xi Y, Zhang Y, Zhu S, Luo Y, Xu P, Huang Z. PPAR-Mediated Toxicology and Applied Pharmacology. Cells 2020;9:E352. [PMID: 32028670 DOI: 10.3390/cells9020352] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 10.0] [Reference Citation Analysis]
13 Yang L, Bian Y, Li Z, Yan Y, Li J, Li W, Zeng L. Identification of potential biomarkers and pathways in ulcerative colitis with combined public mRNA and miRNA expression microarray data analysis. J Gastrointest Oncol 2019;10:847-58. [PMID: 31602322 DOI: 10.21037/jgo.2019.06.06] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
14 Shi L, Liu Q, Tang J, Wen J, Li C. Protective effects of pterostilbene on ulcerative colitis in rats via suppressing NF-κB pathway and activating PPAR-γ. Eur J Inflamm 2019;17:205873921984015. [DOI: 10.1177/2058739219840152] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
15 Baradaran Rahimi V, Rakhshandeh H, Raucci F, Buono B, Shirazinia R, Samzadeh Kermani A, Maione F, Mascolo N, Askari VR. Anti-Inflammatory and Anti-Oxidant Activity of Portulaca oleracea Extract on LPS-Induced Rat Lung Injury. Molecules 2019;24:E139. [PMID: 30609661 DOI: 10.3390/molecules24010139] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 8.0] [Reference Citation Analysis]